Integrum AB (OSTO:INTEG B) E10: kr-1.00 (As of Apr. 2026)


OSTO:INTEG B Integrum AB OSTO:INTEG B
54 GF Score
Price kr8.25
GF Value kr17.76
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Integrum AB E10?

Integrum AB OSTO:INTEG B 54 E10 is kr-1.00 as of Apr. 2026. GuruFocus rates OSTO:INTEG B with a GF Score™ of 54/100 and a GF Value™ of kr17.76 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Integrum AB's adjusted earnings per share data for the three months ended in Apr. 2026 was kr-0.660. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-1.00 for the trailing ten years ended in Apr. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-06), Integrum AB's current stock price is kr8.25. Integrum AB's E10 for the quarter that ended in Apr. 2026 was kr-1.00. Integrum AB's Shiller PE Ratio of today is .


Integrum AB  (OSTO:INTEG B) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Integrum AB E10 Related Terms


Integrum AB E10 Historical Data

* Premium members only.

The historical data trend for Integrum AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrum AB E10 Chart

Integrum AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -1.00

Integrum AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.91 -0.94 -1.00

OSTO:INTEG B vs ABT, SYK, MDT: E10 Comparison

For the Medical Devices subindustry, Integrum AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrum AB Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Integrum AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Integrum AB's Shiller PE Ratio falls into.


OSTO:INTEG B
54GF Score
Integrum AB OSTO:INTEG B
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integrum AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Integrum AB's adjusted earnings per share data for the three months ended in Apr. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=-0.66/132.7900*132.7900
=-0.660

Current CPI (Apr. 2026) = 132.7900.

Integrum AB Quarterly Data

per share eps CPI Adj_EPS
201607 0.374 101.080 0.491
201610 -0.148 101.485 -0.194
201701 -0.136 101.326 -0.178
201704 -0.639 102.615 -0.827
201707 -0.098 103.301 -0.126
201710 -0.267 103.202 -0.344
201801 -0.793 102.925 -1.023
201804 -0.703 104.390 -0.894
201807 -0.561 105.420 -0.707
201810 -0.148 105.545 -0.186
201901 -0.691 104.855 -0.875
201904 -0.673 106.627 -0.838
201907 -0.346 107.166 -0.429
201910 -0.178 107.243 -0.220
202001 -0.257 106.215 -0.321
202004 -0.280 106.240 -0.350
202007 -0.207 107.731 -0.255
202010 0.188 107.539 0.232
202101 0.020 107.897 0.025
202104 -0.148 108.624 -0.181
202107 0.079 109.218 0.096
202110 0.879 110.562 1.056
202201 0.030 111.876 0.036
202204 0.217 115.534 0.249
202207 -0.030 118.489 -0.034
202210 0.128 122.561 0.139
202301 -0.731 124.942 -0.777
202304 -0.326 127.632 -0.339
202307 -0.099 129.464 -0.102
202310 0.217 130.549 0.221
202401 0.039 131.720 0.039
202404 0.118 132.601 0.118
202407 -0.484 132.831 -0.484
202410 -0.474 132.604 -0.475
202501 -0.180 132.943 -0.180
202504 -0.420 132.981 -0.419
202507 -0.464 133.957 -0.460
202510 -0.346 133.830 -0.343
202601 -0.470 133.560 -0.467
202604 -0.660 132.790 -0.660

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of kr-1.00 mean?
Integrum AB (OSTO:INTEG B) has a E10 of kr-1.00 as of Apr. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Integrum AB and its competitors.
Is Integrum AB's E10 too high?
Integrum AB's current E10 is kr-1.00. Overall, Integrum AB has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Integrum AB's E10 compare to ABT and SYK?
Integrum AB's E10 of kr-1.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Integrum AB and its competitors. Integrum AB's current E10 is kr-1.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrum AB stock overvalued right now?
Based on GuruFocus' analysis, Integrum AB (OSTO:INTEG B) is currently considered Possible Value Trap. The stock's GF Value™ is kr17.76, compared to a current price of kr8.25 — trading 53.5% below its estimated fair value. The current E10 is kr-1.00. Integrum AB's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Integrum AB (OSTO:INTEG B), the current E10 is kr-1.00 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integrum AB (OSTO:INTEG B) Overvalued in 2026?

Based on GuruFocus' analysis, Integrum AB stock appears to be undervalued. The current stock price of kr8.25 is trading 53.5% below its estimated GF Value™ of kr17.76. GuruFocus considers Integrum AB to be Possible Value Trap.

Key valuation signals for OSTO:INTEG B:

  • E10: kr-1.00
  • GF Value™: kr17.76 vs. price of kr8.25 (53.5% below fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the OSTO:INTEG B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Integrum AB Business Description

Other Exchanges 6Y1:Germany
Address Krokslatts Fabriker 50, Molndal, SWE, SE-431 37
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
54GF Score

Get the complete analysis for OSTO:INTEG B

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr8.25
Price
kr17.76
GF Value